The debate isn't whether URBN is a good business—it's whether the crowd re-rates it before the numbers force the issue. I think the setup into holiday, backed by buybacks and a conservatively built margin plan, tilts that resolution in shareholders' favor.
Read Article ›Amazon stock has slid back toward the low $240s even as AWS just posted its fastest growth in nearly four years. The bear case is simple and loud: capital spending has swallowed free cash flow. My argument is that this particular cash flow trough is the most defensible one Ama...
Read Article ›The standing critique of Rocket Lab is simple: elite growth, elite vision, no profits, and a valuation that requires everything to go right. The Iridium acquisition is the most direct possible response to that critique, because Iridium is the thing Rocket Lab has never had—a c...
Read Article ›The market spent two years treating Comcast as a structurally challenged broadband utility with a fading media albatross stapled to it, and priced it accordingly. The separation of NBCUniversal and Sky directly attacks that framing by letting a cash-rich, under-cross-sold conn...
Read Article ›What the selloff underweights is that Microsoft has run this play before — it absorbed margin compression during the first Azure buildout and methodically clawed it back as utilization improved — and this time it holds more levers. The first is silicon. Its Cobalt CPU is now d...
Read Article ›The familiar standoff—elite CF monopoly versus a full multiple and a maturing core—resolves in the buyers' favor once you weight the catalysts by how knowable they are. CF is converting toward ALYFTREK on a long exclusivity runway and funding everything else; that is the demon...
Read Article ›This is not a company watching solar demand evaporate; it is a premium hardware franchise re-routing US demand from cash sales onto TPO rails while monetizing a domestic-manufacturing credit annuity that peers can't match. The three things that decide the next two quarters are...
Read Article ›CarMax is deliberately reshaping its earnings mix — trading retail GPU for unit growth while attempting to fund the price competitiveness through cost rather than charity.
Read Article ›The central tension in Dexcom is whether its non-insulin type 2 expansion is a margin-accretive growth wave or a commoditization trap. The resolution is in the sequencing. The catalysts that drive the next several quarters — commercial coverage of all diabetics this summer, G7...
Read Article ›The market is trading this as a comp-recovery story, and the comp has recovered, but the actual swing factor for the next leg of the stock is margin, and specifically North America margin, which is still badly depressed.
Read Article ›Fair Isaac is three businesses welded into one ticker: the FICO Score franchise that sits at the center of nearly every U.S. consumer credit decision, a smaller direct to consumer scores business (myFICO), and an enterprise decisioning software segment built around the FICO Pl...
Read Article ›The market is pricing Match Group as a melting ice cube. The leading indicators say the ice has stopped melting — and the cash machine underneath is being badly underrated. Match Group is a portfolio of dating apps wrapped around two assets that matter and a long tail that mos...
Read Article ›Alphabet is three businesses wearing one ticker: an advertising machine (Search, YouTube, the Google Network) that still throws off the cash, a hyperscale cloud and AI infrastructure arm that has only recently become a real profit center, and a portfolio of long dated bets led...
Read Article ›The company is printing record revenue, expanding swaps share across every major currency, growing international past 40% of the mix, and converting more than $1 billion to free cash flow — yet the stock sits near a 52-week low because investors have fixated on a fee-per-milli...
Read Article ›Warner Bros Discovery offers a mid-to-high-teens gross return to a $31 cash takeout, backed by a buyer with unusually strong financial credibility–meanwhile the DOJ appears constructive; international approvals are accumulating; and the underlying business—particularly streami...
Read Article ›Intuit shares have been cut roughly in half from their 52-week high, recently trading in the low $300s, while Q3 fiscal 2026 revenue grew 10%, guidance was raised, and the highest-growth engines are compounding above 30%. TurboTax Live — Intuit's AI-plus-expert model — is on t...
Read Article ›Blue Bird is a rare niche manufacturer that has beaten guidance fourteen straight quarters, raised its FY2026 outlook twice, and just completed a deal that materially widens its addressable market. At roughly 17x trailing earnings and ~9x forward Adjusted EBITDA, the stock tra...
Read Article ›L3Harris shares have retreated nearly 20% from their 52-week high near $379, creating a compelling entry into what is shaping up as a multi-year earnings inflection. A record $40.7 billion backlog—which management describes as approximately two times revenue coverage—means the...
Read Article ›Lam Research delivered a record March quarter and guided its June quarter to a stunning $6.6 billion in revenue — roughly 10% above consensus at the time. The business is accelerating across memory, foundry, and services. Yet with shares near $318, up close to 300% in the past...
Read Article ›Boston Scientific shares have been cut roughly in half since mid-2025, driven by a guidance cut, competitive headwinds in electrophysiology, softening WATCHMAN procedure volumes, and a Class I pacemaker recall. Yet the company still posted 9.4% organic growth in Q1 2026, is on...
Read Article ›